Are we ready to provide more free ARVs?

The World Health Organisation has raised the level of CD4 cell count at which people living with HIV are eligible for treatment. This certainly comes as good news. However, challenges await. At the moment, Uganda contributes only 10% of the funds needed to fight against the pandemic. Even with the previous level of 350 CD4 cell count, only half of those eligible for treatment were getting it. Experts now believe that with political will, the new target can be achieved, writes, JOHN AGABA

There is good news for people living with HIV. Last month, the World Health Organisation (WHO) released new treatment guidelines, raising the level below which people living with HIV are eligible for free treatment. WHO called upon health authorities worldwide to start early treatment in adults whose CD4 cell count falls to 500 cells per cubic millimetre or less.

John Agaba
New Vision
Read More

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search